Cargando…
HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance
We have previously reported on HIV-1 infected patients who fail anti-retroviral therapy but manage to re-suppress without a regimen change despite harbouring major drug resistance mutations. Here we explore phenotypic drug resistance in such patients in order to better understand this phenomenon. Pa...
Autores principales: | Basson, Adriaan E., Charalambous, Salome, Hoffmann, Christopher J., Morris, Lynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302689/ https://www.ncbi.nlm.nih.gov/pubmed/32555643 http://dx.doi.org/10.1371/journal.pone.0234937 |
Ejemplares similares
-
Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa
por: Mabuto, Tonderai, et al.
Publicado: (2017) -
Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch
por: Johnston, Victoria, et al.
Publicado: (2014) -
Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
por: Bîstrițchi, Ina, et al.
Publicado: (2013) -
Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting: A Cohort Study
por: Velen, Kavindhran, et al.
Publicado: (2013) -
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
por: Hofstra, L. Marije, et al.
Publicado: (2016)